drugset / Trial / NCT06830564

Emergence Agitation of Sevoflurane in Pediatric

NCT06830564

Phase 2/3 Completed 126 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindPrevention

Summary

Low dose nalbuphine versus dexmedetomidine on prevention of emergence agitation in children

Timeline

Start
2024-05-01
Primary completion
2024-11-01
Completion
2024-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Nalbuphine Small molecule 0.1 mg/kg Intravenous

Indications